IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Vivo Capital, LLC

Q3 2019 Holdings

Filed 2019-11-13 | 49 holdings | $878.8K | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Aclaris Therapeutics, Inc.00461U105000COMMON$600.2K82,834,66868.3%
Ascendis Pharma A/S04351P101000000ADR$207.9K2,552,23723.7%
Galmed Pharmaceuticals LtdG63637105000000SHS$48.3K9,610,1565.5%
Orchard Therapeutics plc68570P101000000ADS$22.4K2,805,0352.6%
Soleno Therapeutics, Inc. - Warrant83420313500WARRANT$9188,7720.0%